Publication | Open Access

Development and evaluation of a population pharmacokinetic-pharmacodynamic model of darbepoetin alfa in patients with nonmyeloid malignancies undergoing multicycle chemotherapy

Darbepoetin AlfaOncologyPharmacokinetic ModelingMulticycle ChemotherapyPharmacologyPharmacotherapyAnti-cancer AgentMetronomic ChemotherapyPharmacodynamic ModelingMedicinePopulation Pharmacokinetic-pharmacodynamic ModelPharmacokineticsCancer ResearchDrug DiscoveryDrug Resistance